This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., Instituto Carlos Slim De La Salud, A.c., The Broad Institute, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,268 
1 out of 15 
1 out of 486 
Years Active: 2025
Title: The Innovative Contributions of Edmond Chan
Introduction
Edmond Chan is a notable inventor based in Boston, MA, recognized for his significant contributions to the field of cancer treatment. His work focuses on the therapeutic treatment of microsatellite unstable cancers, which has the potential to impact many lives.
Latest Patents
Edmond Chan holds a patent for a method titled "Therapeutic treatment of microsatellite unstable cancers." This patent outlines compositions and methods for diagnosing and treating or preventing cancers characterized by microsatellite instability (MSI) and impaired mismatch repair (MMR). The disclosure emphasizes the identification of such cancers and the administration of an inhibitor of the WRN helicase as a therapeutic agent.
Career Highlights
Throughout his career, Chan has worked with prestigious organizations, including the Broad Institute, Inc. and Instituto Carlos Slim de la Salud. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Some of his notable coworkers include Francisca Vazquez and Adam Bass, who have contributed to his research endeavors.
Conclusion
Edmond Chan's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His patent and career achievements highlight the importance of advancements in therapeutic methods for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile